Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review (Q33187849)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2003

edit

Language	Label	Description	Also known as
English	Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review	scientific article published in August 2003

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

review article

1 reference

stated in

Europe PubMed Central

title

Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

main subject

systematic review

1 reference

based on heuristic

inferred from title

author

Julia Bohlius

object named as

Julia Bohlius

series ordinal

1

0 references

Guido Schwarzer

series ordinal

3

object named as

Guido Schwarzer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

author name string

Marcel Reiser

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

Andreas Engert

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

published in

British Journal of Haematology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

volume

122

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

page(s)

413-423

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

cites work

Treatment of non-Hodgkin's lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04450.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2141.2003.04450.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

PubMed publication ID

12877668

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12877668

retrieved

23 July 2017

ResearchGate publication ID

10646974

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33187849&oldid=2268445293"